Long-term impact of fecal transplantation in healthy volunteers.

Background: Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effectiveness of its application in the other gastrointestinal diseases. However, in the majority of studies the effects of FMT were evaluated on the patients with initially altered microbiota.

Complete Genome Sequences of Type Strain GUR, with Antitumor Activity, and Its Derivative Strain GURSA1 with an Inactivated Gene.

We present here the complete genome sequence of type strain GUR, a throat isolate from a scarlet fever patient, which has been used to treat cancer patients in the former Soviet Union. We also present the complete genome sequence of its derivative strain GURSA1 with an inactivated gene.